Dr. Christopher Lieu and Michelle Cappel - Biomarker Testing for Colorectal Cancer - Doug Wagner Morning Show

Advances in biomarker testing are transforming colorectal cancer (CRC) treatment, offering patients precision-based therapies tailored to their cancer’s unique profile. Doug spoke with Dr. Christopher Lieu, oncologist, and Michelle Cappel, a colorectal cancer patient who was diagnosed with Stage IV metastatic Colon cancer in 2017. colorectalcancer.org/biomarkers